21![FROVA® (frovatriptan succinate) Tablets DESCRIPTION FROVA (frovatriptan succinate) tablets contain frovatriptan succinate, a selective 5-hydroxytryptamine1 (5-HT1B/1D) receptor subtype agonist, as the active ingredient. FROVA® (frovatriptan succinate) Tablets DESCRIPTION FROVA (frovatriptan succinate) tablets contain frovatriptan succinate, a selective 5-hydroxytryptamine1 (5-HT1B/1D) receptor subtype agonist, as the active ingredient.](https://www.pdfsearch.io/img/04647472e68c5847b0822887a667966c.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2009-04-21 16:03:02
|
---|
22![LACHMANCONSULTANTSERVICF.S,lNC. Westbury, NY[removed]ATTACHMENT 2 LACHMANCONSULTANTSERVICF.S,lNC. Westbury, NY[removed]ATTACHMENT 2](https://www.pdfsearch.io/img/ab81fe299ae2427e50dfaab12292ae7c.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2004-12-01 13:58:11
|
---|
23![Appendix D: Switching Antidepressants Switching antidepressants can be accomplished by the following strategies: 1. Direct switch: stop the first antidepressant abruptly and start new antidepressant the next day. 2. Ta Appendix D: Switching Antidepressants Switching antidepressants can be accomplished by the following strategies: 1. Direct switch: stop the first antidepressant abruptly and start new antidepressant the next day. 2. Ta](https://www.pdfsearch.io/img/e31e2ce58d0deaed095cc6542ddf9bf8.jpg) | Add to Reading ListSource URL: www.bcguidelines.caLanguage: English - Date: 2014-03-03 17:18:50
|
---|
24![Appendix C: First-Line Antidepressants “First-line” antidepressant treatment represents a balance of efficacy, tolerability and expert consideration per the Canadian Network for Mood and Anxiety Treatments (CANMAT) r Appendix C: First-Line Antidepressants “First-line” antidepressant treatment represents a balance of efficacy, tolerability and expert consideration per the Canadian Network for Mood and Anxiety Treatments (CANMAT) r](https://www.pdfsearch.io/img/b1b6ed6fabedb0adffcf6e98c6ee9e24.jpg) | Add to Reading ListSource URL: www.bcguidelines.caLanguage: English - Date: 2014-03-03 17:18:50
|
---|
25![Antidepressant Medicines An Easy-to-Read Guide For People Who Take These Medicines Antidepressant Medicines An Easy-to-Read Guide For People Who Take These Medicines](https://www.pdfsearch.io/img/f93366c88fcde681a3e7ee8f0dfa8e36.jpg) | Add to Reading ListSource URL: nisonger.osu.eduLanguage: English - Date: 2012-04-10 12:52:00
|
---|
26![These highlights do not include all the information needed to use AXERT safely and effectively. See full prescribing information for AXERT. AXERT® (almotriptan malate) TabletsInitial U.S. Approval: 2001 These highlights do not include all the information needed to use AXERT safely and effectively. See full prescribing information for AXERT. AXERT® (almotriptan malate) TabletsInitial U.S. Approval: 2001](https://www.pdfsearch.io/img/968b25316c926ad9bb46d822dc9a4bf9.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
27![Appendix A. Preclinical Summary Appendix A, page 1 of 39
Nonclinical Pharmacology, ADME, and Toxicology Summary Table of Contents Appendix A. Preclinical Summary Appendix A, page 1 of 39
Nonclinical Pharmacology, ADME, and Toxicology Summary Table of Contents](https://www.pdfsearch.io/img/479d9feed34a2847e4a49219afea86f7.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2000-03-23 04:08:32
|
---|
28![Revised: [removed]Axert® (almotriptan malate) Tablets ----------------------------------DRUG INTERACTIONS--------------------------------• Do not use AXERT® and ergotamine-containing or ergot-type medication Revised: [removed]Axert® (almotriptan malate) Tablets ----------------------------------DRUG INTERACTIONS--------------------------------• Do not use AXERT® and ergotamine-containing or ergot-type medication](https://www.pdfsearch.io/img/6477a20fd5bd2b1e2ab0286f7089e31f.jpg) | Add to Reading ListSource URL: www.axert.comLanguage: English - Date: 2012-12-06 16:24:22
|
---|
29![EU PSUR Work Sharing Summary Assessment Report Zomig, Zomig Rapimelt, Zomig Nasal (zolmitriptan) SE/H/PSUR[removed]P-RMS EU PSUR Work Sharing Summary Assessment Report Zomig, Zomig Rapimelt, Zomig Nasal (zolmitriptan) SE/H/PSUR[removed]P-RMS](https://www.pdfsearch.io/img/f872cb8c23afa8cd703c91b9ba4da3b6.jpg) | Add to Reading ListSource URL: www.hma.euLanguage: English - Date: 2014-06-03 10:34:25
|
---|
30![[removed]Summary AR moclobemide [removed]Summary AR moclobemide](https://www.pdfsearch.io/img/4cdcf532d1938060c620d4ec983d50fe.jpg) | Add to Reading ListSource URL: www.hma.euLanguage: English - Date: 2014-05-06 06:23:38
|
---|